BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20302942)

  • 1. High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications.
    Pizarro SA; Gunson J; Field MJ; Dinges R; Khoo S; Dalal M; Lee M; Kaleas KA; Moiseff K; Garnick S; Reilly DE; Laird MW; Schmelzer CH
    Protein Expr Purif; 2010 Aug; 72(2):184-93. PubMed ID: 20302942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
    Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industrial case study: evaluation of a mixed-mode resin for selective capture of a human growth factor recombinantly expressed in E. coli.
    Kaleas KA; Schmelzer CH; Pizarro SA
    J Chromatogr A; 2010 Jan; 1217(2):235-42. PubMed ID: 19647263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokaryotic expression, refolding, and purification of functional human vascular endothelial growth factor isoform 165: purification procedures and refolding conditions revisited.
    Lee IL; Li PS; Yu WL; Shen HH
    Protein Expr Purif; 2011 Mar; 76(1):54-8. PubMed ID: 20826215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
    Petrov S; Nacheva G; Ivanov I
    Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
    Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
    Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-pressure refolding of human vascular endothelial growth factor (VEGF) recombinantly expressed in bacterial inclusion bodies: refolding optimization, and feasibility assessment.
    Cothran A; St John RJ; Schmelzer CH; Pizarro SA
    Biotechnol Prog; 2011; 27(5):1273-81. PubMed ID: 21608142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
    Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
    Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High cell density fed-batch culture of E.coli expressing rhVEGF121].
    Hu ZM; Ma L; Zhou MQ; Meng MJ; Yang JZ; Wang XN
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):267-9. PubMed ID: 15771989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.
    Zhao G; Meier TI; Hoskins J; Jaskunas SR
    Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
    Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
    Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput purification of recombinant human growth hormone using radial flow chromatography.
    Singh SM; Sharma A; Panda AK
    Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.
    Kischnick S; Weber B; Verdino P; Keller W; Sanders EA; Anspach FB; Fiebig H; Cromwell O; Suck R
    Protein Expr Purif; 2006 Jun; 47(2):621-8. PubMed ID: 16495080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning, large-scale production, and purification of active dimeric rat vascular endothelial growth factor (rrVEGF-164).
    Geutjes PJ; Nillesen ST; Lammers G; Daamen WF; van Kuppevelt TH
    Protein Expr Purif; 2010 Jan; 69(1):76-82. PubMed ID: 19733244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Kronbach T; Dettmer D
    Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding and purification of rhNTA protein by chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.